Summary
In five patients single or multiple glucagonomas were characterized by immunocytochemistry. Two large single glucagonomas were associated with the glucagonoma syndrome, which completely dissappeared after removal of the tumours. The morphologic findings in these patients are compared with 48 others collected from literature.
In the other three patients, the glucagonomas were not associated with a clinical syndrome and were detected by chance (one accompanying an insulinoma; the other in pancreases of patients suffering from multiple endocrine neoplasia I; MEN I). These tumours appeared by their histological, immunocytochemical and ultrastructural features better organized than the glucagonomas with syndrome.
Glucagonomas not producing a syndrome can be classified into (a) solitary, often malignant endocrine pancreatic tumours, (b) glucagonomas associated with insulinomas and other tumours, (c) multiple glucagonomas in MEN I and (d) single microglucagonomas in elderly patients. It is emphasized that only immunohistology allows clear identification of these tumours as glucagonomas.
Similar content being viewed by others
References
Adams EB, Scragg JN, Naidoo BT, Liljestrand SK, Cockram VI (1967) Observations on the aetiology and treatment of anaemia in Kwashiorkor. Br Med J 3:451–454
Amon RB, Swenson KH, Hanifin JM, Hambidge KM (1976) The glucagonoma syndrome (necrolytic migratory erythema) and zinc. N Eng J Med 295:962
Auerbach RC, Koehler R (1973) The many faces of islet cell tumors. Am J Roentgenol 119:133–140
Barber SG, Hamer JD (1976) Skin rash in patient receiving glucagon. Lancet 1138
Baetens D, Malaisse-Lagae F, Perrelet A, Orci L (1979) Endocrine pancreas: three-dimensional reconstruction shows two types of islets of Langerhans. Science 206:1323–1325
Becker SW, Kahn D, Rothman S (1942) Cutaneous manifestations of internal malignant tumors. Arch Dermatol Syph 45:1069–1080
Behar M (1970) Disturbance of nutrition. (1) Protein-calorie malnutrition. In: DB Jellife (ed) Diseases of children in the subtropics and tropics. London pp 161–184
Behrendt W (1962) Ein Beitrag zur Pathologie des A-Zellkarzinoms. Zentralbl Allg Pathol Anat 104:199–204
Binnick AN, Spencer SK, Dennison WL, Horton ES (1977) Glucagonoma syndrome. Arch Dermatol 113:749–754
Boden G, Owen OE, Rezvani I, Elfenbein BI, Quickel KE (1977) An islet cell carcinoma containing glucagon and insulin. Diabetes 26:128–137
Bordi C, Bussolati G (1974) Immunofluorescence, histochemical and ultrastructural studies for the detection of multiple endocrine polypeptide tumours of the pancreas. Virchows Arch B Cell Path 17:13–27
Bordi C, Ravazzola M, Beatens D, Gordon P, Unger RH, Orci L (1979) A study of glucagonomas by light and electron mikroscopy and immunfluorescence. Diabetes 28:925–936
Cho KJ, Wilcox CW, Reuter SR (1977) Glucagon-producing islet cell tumor of the pancreas. Am J Roentgenol 129:159–161
Church RE, Crane WAJ (1967) A cutaneous syndrome associated with islet-cell carcinoma of the pancreas. Br J Dermatol 79:284–286
Creutzfeldt W (1977) Endocrine tumors of the pancreas. In: Volk BW, Wellmann KF (eds), The diabetic pancreas, Chapt 22, Plenum Publishing Corporation, New York-London, pp 551–590
Croisier JC, Lehy T, Zeitoun P (1971) A2-cell pancreatic microadenomas in a case of multiple endocrine adenomatosis. Cancer (Philad.) 28:707–713
Croughs RJM (1974) Glucagonoma and A-cell hyperplasia. Clin Gastroenterol 3:609–619
Danforth DN, Triche T, Doppman JL, Beazley RM, Perino PV, Recant L (1976) Elevated plasma proglucagon-like component with a glucagon-secreting tumor. Effect of streptozotocin. N Engl J Med 295:242–245
Friesen SR, Hermreck AS, Mantz FA (1973) Glucagon, gastrin, and carcinoid tumors of the duodenum, pancreas, and stomach: polypeptide “apudomas” of the foregut. Am J Surg 127:90–101
Gössner W, Korting G (1960) Metastasierendes Inselzellkarzinom vom A-Zelltyp bei einem Fall von Pemphigus foliaceus und Diabetes renalis. Dtsch Med Wochenschr 11:434–437
Grimelius L (1968) A silver nitrate stain for A2 cells in human pancreatic islets. Acta Soc Med Upsalien 73:243–270
Grimelius L, Hultquist G, Stenkvist B (1975) Cytological differentiation of asymptomatic pancreatic islet cell tumors in autopsy material. Virchows Arch A Path Anat and Histol 365:275–288
Hamperl H (1952) Über argyrophile Zellen. Virchows Arch 321:482–507
Heitz PhU, Kasper M, Polak JM, Klöppel G (1979) Pathology of the endocrine pancreas. J Histochem Cytochem 27:1401–1402
Hess W (1946) Über ein endokrin inaktives Carcinom der Langerhansschen Inseln. Schw med Wochenschr 35:802–804
Higgins GA, Recant L, Fischmann AB (1979) The glucagonoma syndrome: Surgically curable diabetes. Am J Surg 137:142–148
Holst JJ, Pedersen NB (1975) Glucagon-producing tumors of the pancreas. Acta Endocrinol (KBH) Suppl 199:379
Holst JJ, Jonsson L, Pedersen NB, Thomsen K (1975) Glukagonomsyndromet. Ugeskr Laeger 137:2531–2633
Holst JJ, Helland S, Ingemannson S, Bang Pedersen N, von Schenck H (1979) Functional studies in patients with the glucagonoma syndrome. Diabetologia 17:151–156
Ingemansson S, Holst J, Larsson LI, Lunderquist A (1977) Localization of glucagonomas by cathederization of the pancreatic veins and glucagon assay. Surg Gynecol Obstet 145:509–516
Jaspan JB, Rubenstein AH (1977) Circulating glucagon. Plasma profiles and metabolism in health and disease. Diabetes 26:887–904
Kahan RS, Perez-Figaredo MRA, Neimanis CA (1977) Necrolytic migratory erythema. Arch Dermatoll 13:792–797
Katz R, Fishmann AB, Galotto J, Gucci JG, Higgins A, Ortega LG (1979) Necrolytic migratory erythema, presenting as candidiasis, due to pancreatic glucagonoma. Cancer 44:558–563
Kessinger A, Lemon HM, Foley JF (1977) The glucagonoma syndrome and its management. J Surg Oncol 9:419–424
Klöppel G, Seifert G, Heitz Ph (1979) Endokrine Pankreastumoren. Morphologie und Syndrome. Dtsch Med Wochenschr 104:1571–1577
Kramer S, Machina T, Marcus R (1976) Metabolic studies in the malignant glucagonoma syndrome. Diabetes 25:(Suppl 1), 370
Krebs A, Teuscher A, Armagni C (1978) Syndrome de glucagonome: Manifestations cutanées. Ann Dermatol Venerol (Paris) 105:637–639
Largiadèr F (1977) Endokrin aktive Pankreasgeschwülste. Helv Chir Acta 44:747–756
Larsson LI, Sundler F, Grimelius L, Hakanson R, Holst J (1973) Immunohistochemical demonstration of glucagon in an A2-cell carcinoma. Experientia 29:698–699
Leclere J, Vicari F, Laurent J, Jeanpierre R, Floquet J, Grignon G, Hartemann P (1977) Tumeur insulaire avec diarrhée et diabète (glucagonome?) associée àun hyperparathyroidisme. Ann Endocrinol (Paris) 38:153–154
Leichter SB, Pagliara AS, Greider MH, Pohl S, Rosai J, Kipnis DM (1975) Uncontrolled diabetes mellitus and hyperglucagonemia. Am J Med 58:285–293
Lightman SL, Bloom SR (1974) Cure of insulin-dependent diabetes mellitus by removal of a glucagonoma. Br Med J 1:367–368
Lomsky R, Langr F, Vortel V (1969) Demonstration of glucagon in islet cell adenomas of the pancreas by immunofluorescent technic. Am J Clin Pathol 51:245–250
Mallinson CN, Bloom SR, Warin AP, Salmon PR, Cox B (1974) A glucagonoma syndrome. Lancet 1–5
Mallinson CN, Bloom SR (1974) Plasma levels of amino acids and glucagon in patients with pancreatic glucagonomas. Gut 15:340
Mallinson C, Adrian T, Hanley J, Bryant M, Bloom SR (1977) Metabolic and clinical responses in patients with pancreatic glucagonomas. Ir J Med Sci 146:37–38
Mallinson C, Bloom SR (1978) The hyperglycemic, cutaneous syndrome: pancreatic glucagonoma. In: Friesen SR (ed), Surgical endocrinology: clinical syndromes, Philadelphia Toronto, Lippincott, p 171
McGavran MH, Unger RH, Recant L, Polk HC, Kilo Ch, Levin ME (1966) A glucagon-secreting alpha-cell carcinoma of the pancreas. N Engl J Med 274:1408–1413
Patzelt C, Tager HS, Carroll RJ, Steiner DF (1979) Identification and processing of proglucagon in pancreatic islets. Nature 282:260–266
Pedersen NB, Jonsson L, Holst JJ (1976) Necrolytic migratory erythema and glucagon cell tumor of the pancreas: The glucagonoma syndrome. Acta Dermatol Venerol (Stockholm) 56:391–395
Polak JM, Bloom SR, Adrian TE, Heitz PhU, Bryant MG, Pearse AGE (1976) Pancreatic polypeptide in insulinomas, gastrinomas, vipomas, and glucagonomas. Lancet I:328–330
Ravazzola M, Siperstein A, Moody AJ, Sundby F, Jacobsen H, Orci L (1979) Glicentin immunoreactive cells: their relationship with glucagon producing cells. Endocrinology 105:499–508
Recant L, Perrino PV, Bhathena SJ, Danforth DN, Lavine RL (1976) Plasma immunreactive glucagon fractions in four cases of glucagonoma: Increased “large glucagon-immunoreactivity.” Diabetologia 12:319–326
Riddle MC, Golper TA, Flechter WS, Ensinck JW, Smith PhH (1978) Glucagonoma syndrome in a 19-year-old woman. Western J Med 129:68–72
Schenck H v, Thorell JI, Berg J, Bojs G, Dymling JF (1979) Metabolic studies and glucagon gel filtration pattern before and after surgery in a case of glucagonoma syndrome. Acta Med Scand 205:155–162
Scully RE, McNeely BU (1975) Case records. N Engl J Med 292:1117–1123
Shupack JL, Berczeller PH, Stevens DM (1978) The glucagonoma syndrome. J Dermatol Surg Oncol 4:242–247
Soler NG, Oates GD, Malins JM (1976) Glucagonoma syndrome in a young man. Proc R Soc Med 69:429–431
Sternberger LA (1979) Immunochemistry, 2nd edn Wiley, New York, Chichester, Brisbane, Toronto
Strauss GM, Weitzman SA, Aoki TT (1979) Dimethyltriazenoimidazole Carboximide therapy of malignant glucagonoma. Ann Int Med 90:57–58
Sturner WQ (1972) Sudden death from non-insulin secreting islet cell tumor of the pancreas (“Glucagonoma”). Hum Pathol 3:113–119
Sweet RD (1974) A dermatosis specifically associated with a tumor of pancreatic alpha cells. Br J Dermatol 90:301–308
Swenson KH, Amon RB, Hanifin JM (1978) The glucagonoma syndrome. A distinctive marker of systemic disease. Arch Dermatol 114:224–228
Teuscher A, Studer PP, Krebs A, Berger M, Aberhard P (1979) Diabetesverlauf und klinisches Bild bei Glucagonom. Schweiz Med Wochenschr 109:1273–1280
Tiengo A, Fedele D, Marchiori E, Nosadini R, Muggeo M (1976) Suppression and Stimulation mechanism controlling secretion in a case of islet-cell tumor producing glucagon, insulin, and gastrin. Diabetes 25:408–412
Unger RH, Eisentraut A, Lochner JD (1963) Glucagon-producing tumors of the islets of Langerhans. J Clin Invest 42:987–988
Valverde I, Lemon H, Kessinger A, Unger RH (1976) Distribution of plasma glucagon immunoreactivity in a patient with suspected glucagonoma. J Clin Endocrinol Metab 42:804–808
Warin AP (1974) Necrolytic migratory erythema with carcinoma of pancreas. Proc Soc Med 67:24–26
Weir GC, Horton ES, Aoki TT, Slovik D, Jaspan J, Rubenstein AH (1977) Secretion by glucagonomas of a possible glucagon precursor. J Clin Invest 59:325–330
Weir GC, Novelline RA (1977) The glucagonoma syndrome. Am Fam Physician 16:83–84
Wilkinson DS (1971) Necrolytic migratory erythema with pancreatic carcinoma. Proc R Soc Med 64:26–27
Wilkinson DS (1973) Nekrolytic migratory erythema with carcinom of the pancreas. Trans St Johns Hosp Dermatol Soc 59:244–250
Woodtli W, Hedinger Chr, Amman R, Zimmermann K, Säuberli H (1976) Glucagon-produzierende Inseladenomatose des Pankreas mit polyendokriner Symptomatik. Schw Med Wochenschr 106:749–754
Woodtli W, Hedinger Chr (1977) Inselzelltumoren des Pankreas und ihre Syndrome. Schw Med Wochenschr 107:685–693
Woodtli W, Hedinger Chr (1978) Inselzelltumoren des Pankreas und ihre Syndrome. Schweiz Med Wochenschr 108:1997–2007
Yoshiga T, Okuno G, Shinji Y, Tsujii T, Nishikawa M (1966) Pancreatic A-cell tumor associated with severe Diabetes mellitus. Diabetes 15:709–713
Zhdanov VC (1956) Diabetes and malignancy of islet cells in pancreas (in Russian). Arch Patologii (Moskva) 18:92–93
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ruttman, E., Klöppel, G., Bommer, G. et al. Pancreatic glucagonoma with and without syndrome. Virchows Arch. A Path. Anat. and Histol. 388, 51–67 (1980). https://doi.org/10.1007/BF00430676
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00430676